Prudentix

Company Overview

Snapshot

Founded in January 2016 by Igal Liapis and Dadi Segal, Prudentix operates with 1–10 employees. The company focuses on developing chemical medical devices for oral care and dentistry, holding patents for its formulations.

Business overview

Prudentix is an R&D company specializing in the development of chemical medical devices for oral care and dentistry. The company's core technology involves patented formulations with physico-chemical properties, anti-inflammatory, and healing actions, targeting conditions such as periodontal pockets, gingivitis, halitosis, and general oral hygiene. Prudentix serves the healthcare and consumer goods markets, operating within the Health Tech & Life Sciences sector, specifically in Medical Devices and Pharma & Medical Biotechnology.

Company Intelligence Q&A

What is Prudentix's primary focus?

Prudentix is an R&D company focused on developing chemical medical devices for oral care and dentistry, addressing issues like periodontal pockets, gingivitis, halitosis, and oral hygiene.

Who founded Prudentix?

Prudentix was co-founded by Igal Liapis, who serves as CEO, and Dadi Segal, who is the BD Manager.

What types of products does Prudentix manufacture?

Prudentix manufactures liquid and semi-solid products, as well as those administered in films, tablets, and sprays, all based on patented formulations.

What quality standards does Prudentix adhere to?

Prudentix's products are manufactured under strict quality standards, including ISO 13485 for medical devices, ISO 22716 for cosmetics, and ISO 9001 for general operational quality.

In which markets does Prudentix operate?

Prudentix operates globally, targeting both B2C and B2B business models within the healthcare and consumer goods sectors.